The Effect of Fluids on Aortic VTI During C-section
Launched by BAYLOR COLLEGE OF MEDICINE · Mar 31, 2020
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how different measurements can help doctors understand a pregnant woman's fluid status during a scheduled C-section (a type of surgery to deliver a baby). When women are in labor, it’s important for medical teams to know if they have the right amount of fluids in their bodies, as too little or too much can lead to complications. This study will use echocardiography, a non-invasive imaging technique similar to an ultrasound, to measure specific indicators related to fluid levels in the body.
To be eligible for this trial, participants must be healthy pregnant women aged 18 to 35, who are having a single baby and are at least 37 weeks along in their pregnancy. They must also be scheduled for a planned C-section and able to receive a specific type of anesthesia. Women who have certain health issues, are older than 35, or are having an emergency C-section will not be able to participate. If eligible, participants can expect to undergo simple tests that will help the medical team assess their fluid status safely and easily. This research aims to improve care for women during labor and delivery by finding better ways to monitor their health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • healthy nulliparous or multiparous pregnant women with a term (\>37 weeks gestation)
- • age 18-35
- • singleton pregnancy
- • scheduled for Cesarean delivery with planned neuraxial spinal or combined spinal epidural anesthesia
- • American Society for Anesthesiologists physical status 2
- Exclusion Criteria:
- • Patients without ability to provide informed consent
- • American Society for Anesthesiologists physical status 3 or 4
- • Emergency cesarean section
- • BMI\>40
- • Known cardiac and pulmonary comorbidities including chronic hypertension, preeclampsia, gestational hypertension, diabetes, asthma, renal disease
- • Age \> 35
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Amy Lee, MD
Principal Investigator
Baylor College of Medicine
Yi Deng, MD
Study Director
Baylor College of Medicine
Claudia Wei, MD
Principal Investigator
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials